Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04640207 · ClinicalTrials.gov registry record · NA
The Efficacy of the Alma Hybrid System for a New Approach of Facial Skin Treatment
A NA study, sponsored by Alma Lasers.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT04640207 is a NA study that has completed, run by Alma Lasers. The registered enrollment target is 22 participants.
The verdict
NCT04640207, a NA study, has completed, sponsored by Alma Lasers.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The study is aimed to evaluate the efficacy of the Alma Hybrid system for a new approach of facial skin treatment, using both ablative and non-ablative wavelengths. The study will include 20 subjects with mild-moderate photodamaged skin, that will undergo 2 facial skin treatments. Follow up visit to evaluate the efficacy of the treatments will take place 1 and 3 months after the last treatment.
Interventions
- DEVICE Facial skin treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-11-25 |
| Est. Completion | 2021-07-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04640207
The ClinicalTrials.gov registry entry for NCT04640207 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alma Lasers, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Facial skin treatment is the first listed.
NCT04640207 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04640207 about?
NCT04640207 is a clinical study titled "The Efficacy of the Alma Hybrid System for a New Approach of Facial Skin Treatment". The study is aimed to evaluate the efficacy of the Alma Hybrid system for a new approach of facial skin treatment, using both ablative and non-ablative wavelengths. The study will include 20 subjects with mild-moderate photodamaged skin, that will undergo 2 facial skin treatments. Follow up visit t...
What is the current status of trial NCT04640207?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2020-11-25. Estimated completion is 2021-07-18.
What interventions are being tested in trial NCT04640207?
The interventions under investigation include: Facial skin treatment (DEVICE).
Who is sponsoring clinical trial NCT04640207?
This trial is sponsored by Alma Lasers, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.